SCHEMBL22985445

SCHEMBL22985445

N#Cc1cc(C(F)(F)F)ccc1-c1cccc(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)c1-c1c(C#N)cccc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
XDH P47989 1/20 0.34
AR P10275 4/20 0.34
PTPN5 P54829 2/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
KIF11 P52732 1/20 0.33
SSTR2 P30874 1/20 0.33
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985450 0.97 ALOX5AP (0.34) ALOX5APFEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL22985319 0.93 KIF11 (0.40) ALOX5APFEN1ARPTPN5KIF11
SCHEMBL22985426 0.93 ALOX5AP (0.40) ALOX5APFEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL22985179 0.92 AR (0.39) ALOX5APFEN1SMN1; SMN2MAPTXDH
SCHEMBL22985427 0.92 MAT2A (0.39) ALOX5APFEN1XDHARPTPN5
SCHEMBL22985431 0.92 ALOX5AP (0.36) ALOX5APFEN1ALDH1A1SMN1; SMN2XDH
SCHEMBL22984986 0.92 KIF11 (0.37) ALOX5APFEN1ARPTPN5KIF11
SCHEMBL22985183 0.92 AR (0.43) ALOX5APFEN1SMN1; SMN2XDHAR
SCHEMBL22985184 0.91 AR (0.36) ALOX5APFEN1SMN1; SMN2XDHAR
SCHEMBL22985648 0.91 ALOX5AP (0.35) ALOX5APFEN1SMN1; SMN2ARPTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885ALDH1A1 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.